Blog

Nelson Dusetti

Mar 25, 2025, 11:05

Nelson Dusetti: PANCprofiler – A step forward in personalizing pancreatic cancer treatment

Nelson Dusetti, Head of the Translational Research and Innovative Therapies Department at the Cancer Research Centre of Marseille (CRCM), shared a post on LinkedIn:

“A step forward in personalizing pancreatic cancer treatment!

We were honored to present our latest work at JFHODs, where we unveiled for the first time the development of PANCprofiler, an innovative transcriptomic signature based on deconvolution, designed to detect multidrug-resistant cells within pancreatic tumors.

A great achievement by Nicolas Fraunhoffer and the Marseille Pancreatic Cancer Team!”

Nelson Dusetti: PANCprofiler - A step forward in personalizing pancreatic cancer treatment

cancer Cancer Research Centre of Marseille CRCM fight against cancer Global fight against cancer JFHODs Marseille Pancreatic Cancer Team Nelson Dusetti. Nicolas Fraunhoffer OncoDaily Oncology PANCprofiler Pancreatic Cancer

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Paolo Tarantino: AACR Journals' Power Move for Reviewers

Best Immunotherapy Highlights from ESMO TAT ASIA 2025 You Shouldn't Miss

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership

Mohit Manrao: FDA Grants Priority Review for sBLA in Resectable Early-Stage Gastric and GEJ Cancers